Synthetic B-Cell Epitopes Eliciting Cross-Neutralizing Antibodies: Strategies for Future Dengue Vaccine
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synthetic B-Cell Epitopes Eliciting Cross-Neutralizing Antibodies: Strategies for Future Dengue Vaccine
Authors
Keywords
Enzyme-linked immunoassays, Antibodies, Vaccines, B cells, Dengue virus, Antibody response, Antigens, Viral vaccines
Journal
PLoS One
Volume 11, Issue 5, Pages e0155900
Publisher
Public Library of Science (PLoS)
Online
2016-05-26
DOI
10.1371/journal.pone.0155900
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An Adjuvanted, Tetravalent Dengue Virus Purified Inactivated Vaccine Candidate Induces Long-Lasting and Protective Antibody Responses Against Dengue Challenge in Rhesus Macaques
- (2015) Stefan Fernandez et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- 2013 Dengue Outbreaks in Singapore and Malaysia Caused by Different Viral Strains
- (2015) Lee-Ching Ng et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive Antibodies
- (2015) Wen-Yang Tsai et al. JOURNAL OF VIROLOGY
- Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America
- (2015) Luis Villar et al. NEW ENGLAND JOURNAL OF MEDICINE
- The dengue vaccine pipeline: Implications for the future of dengue control
- (2015) Lauren M. Schwartz et al. VACCINE
- Comprehensive mapping of functional epitopes on dengue virus glycoprotein E DIII for binding to broadly neutralizing antibodies 4E11 and 4E5A by phage display
- (2015) Julia C. Frei et al. VIROLOGY
- A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins
- (2015) Guntur Fibriansah et al. Nature Communications
- Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial
- (2014) Maria Rosario Capeding et al. LANCET
- Evaluation of tetravalent and conserved synthetic peptides vaccines derived from Dengue virus Envelope domain I and II
- (2014) Raissa Prado Rocha et al. VIRUS RESEARCH
- Identifying protective dengue vaccines: Guide to mastering an empirical process
- (2013) Scott B. Halstead VACCINE
- Role of T-cell epitope-based vaccine in prophylactic and therapeutic applications
- (2012) James S Testa et al. Future Virology
- Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions
- (2012) R. de Alwis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cross-reactive neutralizing antibody epitopes against Enterovirus 71 identified by an in silico approach
- (2012) K. Kirk et al. VACCINE
- Analysis of Epitopes on Dengue Virus Envelope Protein Recognized by Monoclonal Antibodies and Polyclonal Human Sera by a High Throughput Assay
- (2012) Hong-En Lin et al. PLoS Neglected Tropical Diseases
- Immune Response to Dengue Virus and Prospects for a Vaccine
- (2011) Brian R. Murphy et al. Annual Review of Immunology
- Synthetic peptides containing B- and T-cell epitope of dengue virus-2 E domain III provoked B- and T-cell responses
- (2011) Shanfeng Li et al. VACCINE
- The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced disease
- (2011) Beth-Ann G. Coller et al. VACCINE
- The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing Activity
- (2010) Martina Beltramello et al. Cell Host & Microbe
- Peptide Inhibitors of Flavivirus Entry Derived from the E Protein Stem
- (2010) A. G. Schmidt et al. JOURNAL OF VIROLOGY
- Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes
- (2010) Scott B Halstead et al. LANCET INFECTIOUS DISEASES
- Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans
- (2010) W. Dejnirattisai et al. SCIENCE
- Enhancement of anti-DIII antibodies by the C3d derivative P28 results in lower viral titers and augments protection in mice
- (2010) Matthew D Dunn et al. Virology Journal
- Immunogenicity of novel Dengue virus epitopes identified by bioinformatic analysis
- (2010) Gilma Sánchez-Burgos et al. VIRUS RESEARCH
- On a mouse monoclonal antibody that neutralizes all four dengue virus serotypes
- (2009) R. Rajamanonmani et al. JOURNAL OF GENERAL VIROLOGY
- Humoral Immune Responses of Dengue Fever Patients Using Epitope-Specific Serotype-2 Virus-Like Particle Antigens
- (2009) Wayne D. Crill et al. PLoS One
- Identification of Continuous Human B-Cell Epitopes in the Envelope Glycoprotein of Dengue Virus Type 3 (DENV-3)
- (2009) Andréa N. M. Rangel da Silva et al. PLoS One
- Use of synthetic peptides to represent surface-exposed epitopes defined by neutralizing dengue complex- and flavivirus group-reactive monoclonal antibodies on the native dengue type-2 virus envelope glycoprotein
- (2008) A. K. I. Falconar JOURNAL OF GENERAL VIROLOGY
- Characterization of Dengue Virus Complex-Specific Neutralizing Epitopes on Envelope Protein Domain III of Dengue 2 Virus
- (2008) G. D. Gromowski et al. JOURNAL OF VIROLOGY
- Antibodies to Envelope Glycoprotein of Dengue Virus during the Natural Course of Infection Are Predominantly Cross-Reactive and Recognize Epitopes Containing Highly Conserved Residues at the Fusion Loop of Domain II
- (2008) C.-Y. Lai et al. JOURNAL OF VIROLOGY
- A novel dengue vaccine candidate that induces cross-neutralizing antibodies and memory immunity
- (2008) Chih-Hsiang Leng et al. MICROBES AND INFECTION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started